Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing cholangitis

P J Marotta1, N F LaRusso, R H Wiesner

  • 1Division of Liver Transplantation, Mayo Clinic, Rochester, MN 55905, USA.

Bailliere'S Clinical Gastroenterology
|March 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions between chronic liver disease and inflammatory bowel disease.

Inflammatory bowel diseases·2013
Same author

Spontaneous clearance of hepatitis C after liver and renal transplantation.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2009
Same author

Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2009
Same author

A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation.

Kidney international·2007
Same author

Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism.

American journal of physiology. Gastrointestinal and liver physiology·2007
Same author

Biliary tract physiology.

Current opinion in gastroenterology·2006
Same journal

Index.

Bailliere's clinical gastroenterology·2020
Same journal

Home enteral and parenteral nutrition in children.

Bailliere's clinical gastroenterology·1999
Same journal

Nutritional support in malnourished paediatric patients.

Bailliere's clinical gastroenterology·1999
Same journal

Cholestasis and end-stage liver disease.

Bailliere's clinical gastroenterology·1999
Same journal

Cystic fibrosis: nutritional consequences and management.

Bailliere's clinical gastroenterology·1999
Same journal

Pancreatic diseases (excluding cystic fibrosis).

Bailliere's clinical gastroenterology·1999
See all related articles

Primary sclerosing cholangitis (PSC) is a chronic liver disease often linked with inflammatory bowel disease. Understanding its cause is key to developing effective treatments beyond liver transplantation for this progressive condition.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Autoimmune Diseases

Background:

  • Primary sclerosing cholangitis (PSC) is a rare, chronic liver condition causing bile duct inflammation and damage.
  • PSC often co-occurs with inflammatory bowel disease, particularly ulcerative colitis.
  • The exact causes of PSC remain unknown, complicating treatment strategies.

Purpose of the Study:

  • To summarize the current understanding of primary sclerosing cholangitis.
  • To highlight the diagnostic criteria and clinical presentation of PSC.
  • To review the natural history and current treatment options for PSC.

Main Methods:

  • Literature review of existing studies on PSC.
  • Analysis of clinical data and diagnostic markers for PSC.

Related Experiment Videos

  • Evaluation of the progression and outcomes in PSC patients.

    • Main Results:

    • PSC is characterized by progressive bile duct obstruction and liver damage.
    • Common symptoms include fatigue, itching, and jaundice.
    • Complications include portal hypertension and biliary cirrhosis.

    Conclusions:

    • PSC is a serious liver disease with no current medical cure.
    • Liver transplantation is the only definitive treatment for end-stage PSC.
    • Further research into PSC aetiopathogenesis is crucial for developing targeted therapies.